M. Rowley

592 total citations
17 papers, 301 citations indexed

About

M. Rowley is a scholar working on Oncology, Molecular Biology and Biophysics. According to data from OpenAlex, M. Rowley has authored 17 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Biophysics. Recurrent topics in M. Rowley's work include Advanced Fluorescence Microscopy Techniques (5 papers), Cell Image Analysis Techniques (3 papers) and Acute Myeloid Leukemia Research (2 papers). M. Rowley is often cited by papers focused on Advanced Fluorescence Microscopy Techniques (5 papers), Cell Image Analysis Techniques (3 papers) and Acute Myeloid Leukemia Research (2 papers). M. Rowley collaborates with scholars based in United Kingdom, Sweden and Australia. M. Rowley's co-authors include A C C Coolen, Paul R. Barber, Borivoj Vojnovic, Simon Ameer‐Beg, Mieke Van Hemelrijck, C. Smith, Iain D. C. Tullis, PM Parikh, Lars Holmberg and Hans Garmo and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

M. Rowley

17 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Rowley United Kingdom 11 100 92 69 60 51 17 301
Laura Ferrer‐Font New Zealand 9 55 0.6× 209 2.3× 40 0.6× 21 0.3× 19 0.4× 23 338
Yu Weng China 11 51 0.5× 186 2.0× 83 1.2× 14 0.2× 13 0.3× 14 333
Kanchan Kantekure United States 9 9 0.1× 81 0.9× 60 0.9× 21 0.3× 19 0.4× 12 243
Hauke Winkelmann Germany 6 18 0.2× 97 1.1× 74 1.1× 44 0.7× 42 0.8× 7 237
Shinichiro Tahara Japan 12 64 0.6× 208 2.3× 116 1.7× 4 0.1× 22 0.4× 35 449
Nara de Matos Granja United States 5 118 1.2× 139 1.5× 137 2.0× 5 0.1× 90 1.8× 5 358
Marina Kartachova Netherlands 8 10 0.1× 185 2.0× 40 0.6× 16 0.3× 158 3.1× 13 355
Maddalena M. Bolognesi Italy 11 68 0.7× 210 2.3× 96 1.4× 3 0.1× 31 0.6× 27 362
Meifang Xu China 11 32 0.3× 97 1.1× 129 1.9× 3 0.1× 25 0.5× 30 286
Amelia Au‐Yeung United States 5 36 0.4× 112 1.2× 176 2.6× 6 0.1× 11 0.2× 7 343

Countries citing papers authored by M. Rowley

Since Specialization
Citations

This map shows the geographic impact of M. Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rowley more than expected).

Fields of papers citing papers by M. Rowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rowley. The network helps show where M. Rowley may publish in the future.

Co-authorship network of co-authors of M. Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rowley. A scholar is included among the top collaborators of M. Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rowley. M. Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Häggström, Christel, M. Rowley, Fredrik Liedberg, A C C Coolen, & Lars Holmberg. (2023). Latent heterogeneity of muscle‐invasive bladder cancer in patient characteristics and survival: A population‐based nation‐wide study in the Bladder Cancer Data Base Sweden (BladderBaSe). Cancer Medicine. 12(12). 13856–13864. 1 indexed citations
2.
Barber, Paul R., Gregory Weitsman, Katherine Lawler, et al.. (2019). HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial. JNCI Journal of the National Cancer Institute. 112(9). 944–954. 8 indexed citations
3.
Häggström, Christel, Mieke Van Hemelrijck, Hans Garmo, et al.. (2018). Heterogeneity in risk of prostate cancer: ASwedish population‐based cohort study of competing risks and Type 2 diabetes mellitus. International Journal of Cancer. 143(8). 1868–1875. 9 indexed citations
4.
Rowley, M., Hans Garmo, Mieke Van Hemelrijck, et al.. (2017). A latent class model for competing risks. Statistics in Medicine. 36(13). 2100–2119. 10 indexed citations
5.
Weitsman, Gregory, Paul R. Barber, Lan K. Nguyen, et al.. (2016). HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status. Oncotarget. 7(32). 51012–51026. 25 indexed citations
6.
Rowley, M., A C C Coolen, Borivoj Vojnovic, & Paul R. Barber. (2016). Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging. PLoS ONE. 11(6). e0158404–e0158404. 36 indexed citations
7.
Wulaningsih, Wahyu, Mariam Vahdaninia, M. Rowley, et al.. (2015). Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis. BMC Cancer. 15(1). 913–913. 24 indexed citations
8.
Barber, Paul R., Iain D. C. Tullis, M. Rowley, et al.. (2014). The Gray Institute open microscopes applied to radiobiology and protein interaction studies. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 8949. 89490D–89490D. 6 indexed citations
9.
Barber, Paul R., Iain D. C. Tullis, Robert G. Newman, et al.. (2013). The Gray Institute ‘open’ high‐content, fluorescence lifetime microscopes. Journal of Microscopy. 251(2). 154–167. 24 indexed citations
10.
Rowley, M., Paul R. Barber, A C C Coolen, & Borivoj Vojnovic. (2011). Bayesian analysis of fluorescence lifetime imaging data. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7903. 790325–790325. 42 indexed citations
11.
Barber, Paul R., et al.. (2010). A Bayesian method for single molecule, fluorescence burst analysis. Biomedical Optics Express. 1(4). 1148–1148. 28 indexed citations
12.
Rowley, M., et al.. (2005). Severe gestational (incidental) thrombocytopenia: To treat or not to treat. Hematology. 10(1). 69–72. 20 indexed citations
13.
Alvares, Caroline, et al.. (2004). Remission induced by Campath-1H for thymoma-associated agranulocytosis. Annals of Hematology. 83(6). 398–400. 14 indexed citations
14.
Kouriefs, Chryssanthos, et al.. (2002). Finasteride‐induced thrombocytopenia. British Journal of Urology. 90(3). 348–349. 1 indexed citations
15.
Brada, M., M. Rowley, David Grant, S. Ashley, & TJ Powles. (1990). Hypercalcaemia in Patients with Disseminated Breast Cancer. Acta Oncologica. 29(5). 577–580. 11 indexed citations
16.
Parikh, PM, R Powles, J Treleaven, et al.. (1990). High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study. British Journal of Cancer. 62(5). 830–833. 8 indexed citations
17.
Powles, R, Jonathan A. Rose, J Treleaven, et al.. (1990). Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.. PubMed. 6(1). 17–20. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026